CENP-A overexpression and mislocalization have been observed in many cancers, correlating with disease stage, increased risk of disease progression and poor patient survival (Saha et al., 2020; Smith and Sheltzer, 2022; Wang et al., 2021; Xu et al., 2020; Zhang et al., 2016). The gene discussed is CENPA; the disease is cancer.